Related Experiment Video
Updated: Jul 9, 2026

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
Published on: August 4, 2023
Pre-eclampsia
Baha Sibai1, Gus Dekker, Michael Kupferminc
1Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML 0526, Cincinnati, OH 45267, USA. baha.sibai@uc.edu
Pre-eclampsia, a leading cause of maternal mortality, stems from placental issues and immune responses. Early detection and management are crucial, but effective prediction and prevention strategies remain limited.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Immunology
Background:
- Pre-eclampsia significantly contributes to maternal and perinatal mortality and morbidity.
- Pathogenesis involves superficial placentation, immune maladaptation, and altered angiogenic factors.
- Current risk identification relies on clinical factors, lacking clear diagnostic criteria or biomarkers.
Purpose of the Study:
- To review current findings on pre-eclampsia diagnosis, risk factors, and pathogenesis.
- To assess the present status of pre-eclampsia prediction, prevention, and management.
- To highlight the need for improved diagnostic and therapeutic strategies.
Main Methods:
- Literature review of studies on pre-eclampsia.
- Analysis of epidemiological and clinical risk factors.
- Evaluation of current diagnostic criteria and biomarkers.
- Review of management and intervention strategies.
Main Results:
- Superficial placentation and immune maladaptation are key pathogenetic factors.
- Reduced angiogenic factors and increased placental debris contribute to maternal inflammatory response.
- Maternal cardiovascular and metabolic health modulate pre-eclampsia phenotype.
- Existing interventions to prolong pregnancy lack strong evidence.
Conclusions:
- Pre-eclampsia pathogenesis is multifactorial, involving placental and maternal factors.
- There is a critical need for validated biomarkers for early diagnosis and risk prediction.
- Current management focuses on prenatal care and timely delivery; novel prevention and treatment strategies are required.
Related Concept Videos
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Teratogenicity
Disorders of the Female Reproductive System
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Mitral Valve Prolapse III: Nursing Management
Development of the Oral Microbiota

